What is the recommended prophylaxis for health personnel working in a plague ward?
What is the current Global strategy for malaria control called?
What is the drug of choice for Falciparum Malaria?
Which mosquito species is recognized as the principal secondary vector for Zika virus transmission globally?
What is the usual method of collecting a sample of urine to detect UTI?
Identify A and B in the image of the mosquito larvae given
Under IDSP, which diseases are included under sentinel surveillance?
Which of the following is the National Deworming Day?
Which of the following is the vector responsible for transmitting Orientia tsutsugamushi?
Hand washing during COVID-19 is what level of prevention?
Explanation: **Explanation:** The correct answer is **C. A course of tetracycline**. **Medical Concept:** Plague, caused by *Yersinia pestis*, is a highly infectious disease. Health personnel working in plague wards are at high risk of exposure to pneumonic plague, which spreads via respiratory droplets. For post-exposure prophylaxis (PEP) or for those in close contact with patients, **chemoprophylaxis** is the gold standard. A short course (usually 7 days) of **Tetracycline** (or Doxycycline) is recommended to prevent the onset of the disease. **Analysis of Options:** * **A. Vaccine:** Plague vaccines (killed or live attenuated) are primarily used for pre-exposure prophylaxis in high-risk laboratory workers. They are **not** effective for immediate protection in an outbreak or ward setting because they take time to induce immunity and do not protect against pneumonic plague effectively. * **B. Tetracycline throughout the duty:** Chemoprophylaxis is administered as a fixed **course** (7 days) rather than indefinitely throughout the duty period to minimize toxicity and the risk of antibiotic resistance. * **D. Vaccine and Erythromycin:** Erythromycin is not the first-line drug for plague prophylaxis. Tetracyclines and Sulfonamides are preferred. As mentioned, the vaccine has no role in immediate post-exposure management. **High-Yield Pearls for NEET-PG:** * **Drug of Choice (DOC) for Treatment:** Streptomycin (Gentamicin is an alternative). * **DOC for Prophylaxis:** Tetracycline or Doxycycline. * **Vector:** Rat flea (*Xenopsylla cheopis*). * **Quarantine Period:** 6 days (International Health Regulations). * **Diagnostic Test:** Wayson stain (shows characteristic "safety-pin" appearance).
Explanation: **Explanation:** **Roll Back Malaria (RBM)** is the correct answer as it represents the current global strategic framework for addressing malaria. Launched in **1998** by the WHO, UNICEF, UNDP, and the World Bank, its primary goal is to coordinate international action to reduce the malaria burden through evidence-based interventions like Long-Lasting Insecticidal Nets (LLINs), Indoor Residual Spraying (IRS), and Artemisinin-based Combination Therapy (ACT). **Analysis of Incorrect Options:** * **Modified Plan of Operation (MPO):** Launched in India in **1977**, this was a specific national strategy introduced after the resurgence of malaria in the mid-70s. It shifted the focus from total eradication to "effective control." * **Malaria Eradication Programme:** This refers to the **Global Malaria Eradication Programme (GMEP)** launched by the WHO in **1955**. It was eventually abandoned in 1969 due to the emergence of drug resistance (Chloroquine) and insecticide resistance (DDT). * **Malaria Control Programme:** This is a generic term. While India started the National Malaria Control Programme (NMCP) in **1953**, it is not the name of the current "Global Strategy." **High-Yield Clinical Pearls for NEET-PG:** * **National Framework for Malaria Elimination (NFME) 2016–2030:** India’s current roadmap aiming for a malaria-free country by **2030**. * **World Malaria Day:** Observed on **April 25th**. * **Drug of Choice:** ACT is the mainstay for *P. falciparum*; Chloroquine remains the drug of choice for *P. vivax* (provided there is no resistance). * **E-2025 Initiative:** A WHO initiative supporting 25 countries that have the potential to eliminate malaria by 2025.
Explanation: **Explanation:** The current National Drug Policy for Malaria in India (NVBDCP guidelines) mandates **Artemisinin-based Combination Therapy (ACT)** as the first-line treatment for all cases of *Plasmodium falciparum* malaria. The underlying medical concept is to combat widespread drug resistance and ensure rapid parasite clearance. ACTs combine a fast-acting artemisinin derivative (which reduces the parasite biomass quickly) with a long-acting partner drug (which eliminates remaining parasites and prevents recrudescence). **Analysis of Options:** * **Chloroquine (A):** While it remains the drug of choice for *P. vivax* in most regions, it is no longer used for *P. falciparum* due to high levels of chloroquine resistance (CQR) globally and across India. * **Mefloquine (B):** This is primarily used for chemoprophylaxis in travelers or as a partner drug within an ACT (e.g., Artesunate + Mefloquine). It is not used as a monotherapy for treatment due to neuropsychiatric side effects and resistance. * **Proguanil (C):** This is a folate antagonist used mainly for prophylaxis (often in combination with Atovaquone) rather than the acute treatment of falciparum malaria. **High-Yield Clinical Pearls for NEET-PG:** 1. **ACT Regimen in India:** The standard ACT used is **Artesunate (3 days) + Sulphadoxine-Pyrimethamine (1 day)**. 2. **North-East Exception:** In North-Eastern states (where SP resistance is high), the recommended ACT is **Artemether + Lumefantrine**. 3. **Gametocidal Action:** A single dose of **Primaquine (0.75 mg/kg)** is added on Day 2 to all *P. falciparum* cases to prevent transmission (except in pregnancy/infancy). 4. **Severe Malaria:** The drug of choice is **Intravenous (IV) Artesunate** for at least 24 hours, regardless of the species.
Explanation: ***Aedes albopictus*** - This mosquito, commonly known as the **Asian tiger mosquito**, is recognized as the **principal secondary vector** for Zika virus transmission globally. - It is a competent vector capable of transmitting **Zika**, **Dengue**, and **Chikungunya** viruses across multiple continents including Asia, Europe, Africa, and the Americas. - While *Aedes aegypti* remains the primary vector, *Aedes albopictus* plays a significant role in Zika transmission, particularly in temperate regions where *Ae. aegypti* is less prevalent. - Its adaptability to diverse climates and ability to breed in natural and artificial water containers make it epidemiologically important. *Aedes polynesiensis* - This species is primarily known as a vector for **lymphatic filariasis** (*Wuchereria bancrofti*) in Pacific islands. - While it was involved in Zika virus transmission during the **French Polynesia outbreak (2013-2014)**, it is geographically restricted and not considered a principal vector for global Zika transmission. - Its role is limited to specific Pacific island populations. *Aedes australis* - This species is endemic to Australia and transmits **Ross River virus** and other Australian arboviruses. - It is **not** a recognized vector for Zika virus transmission. - Its geographical distribution and host preferences exclude it from the Zika transmission cycle. *Aedes mitchellae* - This species is not documented in major public health literature as a vector for Zika virus. - It belongs to a mosquito species complex with no established role in arboviral transmission to humans. - Epidemiologically insignificant for Zika virus transmission.
Explanation: ***Midstream catch*** - This technique is the *standard, non-invasive method* for routine urine culture as it minimizes **contamination** from bacteria residing in the distal urethra and periurethral area. - By discarding the initial urine (starting stream) and collecting the middle portion, the sample is more representative of the urine contained within the **bladder**. *Early morning sample* - While an early morning sample is often preferred for optimal concentration (e.g., detecting **proteinuria** or **casts**), it is not the methodology for *minimizing contamination*. - The collection technique (midstream) is more critical than the time of day for ensuring a reliable sample for **UTI culture**. *Suprapubic catheter* - Suprapubic aspiration (SPA) provides an **uncontaminated specimen** (often considered the gold standard), but it is an invasive procedure requiring a needle insertion into the bladder. - It is reserved for specific situations, such as neonates or patients with ambiguous results, and is not the **usual** collection method. *Starting stream collection* - The starting stream is most likely to be contaminated with **urethral flora** (e.g., *Staphylococcus epidermidis* or environmental organisms). - Collecting the starting stream significantly increases the chance of **false positive** culture results, confusing the diagnosis of a true **UTI**.
Explanation: ***A-Anopheles, B-Culex*** - Larva A is identified as **Anopheles** because it rests **parallel** to the water surface and lacks a respiratory **siphon**, breathing through palmate hairs on its abdominal segments. - Larva B is identified as **Culex** as it hangs at an **angle** to the water surface and breathes through a long, narrow respiratory **siphon**. *A-Culex, B-Aedes* - This is incorrect as larva A exhibits the characteristics of **Anopheles** (no siphon, parallel resting), not **Culex**. - While **Aedes** larvae also hang at an angle, larva B's long siphon is more typical of **Culex**; **Aedes** larvae usually have a shorter, stouter siphon. *A-Culex, B-Anopheles* - This option incorrectly reverses the identities. Larva A is **Anopheles** and larva B is **Culex** based on their distinct resting postures and respiratory structures. - The key differentiating feature is the presence of a **siphon** in B (**Culex**) and its absence in A (**Anopheles**). *A-Anopheles, B-Mansonia* - Although the identification of A as **Anopheles** is correct, larva B is not **Mansonia**. - **Mansonia** larvae are unique as they attach to the roots of aquatic plants to obtain oxygen and do not hang from the surface, unlike the larva shown in B.
Explanation: ***HIV + HBV***- **Sentinel surveillance** under IDSP is utilized for diseases where continuous monitoring of specific, defined sites (sentinel sites) provides crucial incidence or prevalence trends, such as **HIV** and **Hepatitis B Virus (HBV)**.- This method is essential for monitoring these diseases as it provides reliable data on prevalence and long-term trends, often focusing on high-risk or specific population groups.*HIV + TB*- While **HIV** is included in sentinel surveillance, **Tuberculosis (TB)** is primarily monitored through **passive surveillance** using mandatory case notification to track incidence and treatment outcomes.- TB is a reportable disease utilizing a robust notification system (e.g., Nikshay portal in India), which differs from the specialized, site-specific sampling used for sentinel surveillance.*Malaria + Dengue*- **Malaria** and **Dengue** are typically included in **syndromic and presumptive surveillance** streams under IDSP due to their potential for rapid outbreaks and the need for immediate, widespread reporting.- Monitoring for these vector-borne diseases focuses on early detection of outbreaks involving fever in defined geographical areas, rather than long-term prevalence trends at specialized sentinel sites.*Measles + Diphtheria*- These diseases are **vaccine-preventable diseases** and are monitored using **enhanced surveillance** protocols to achieve elimination/eradication targets.- Enhanced surveillance requires immediate investigation and reporting of every suspected case to track coverage gaps and initiate immediate public health measures, differing from the sentinel approach.
Explanation: ***10th February*** - The **National Deworming Day (NDD)** is observed annually on **February 10th** across India as the primary national observance to combat **Soil-Transmitted Helminths (STH)** infections - This day involves mass administration of **Albendazole** to children and adolescents (typically 1-19 years) through schools and Anganwadi centres - This is the officially recognized date for the **first annual round** of the national campaign *10th August* - While this date is used for deworming, it serves as the designated date for the **second round** or **follow-up dose** in states using a biannual strategy - This is not the primary National Deworming Day; **February 10th** remains the nationally recognized date for the official observance *10th March* - This date is incorrect and not officially associated with the **National Deworming Day** in India - The official campaign date is fixed to ensure standardized, synchronized provision of **Albendazole** nationwide *11th January* - **January 11th** is not the recognized date for either the first or second round of the **National Deworming Day** campaign - The program's schedule is intentionally set in February and August to maximize coverage and minimize disruption to academic schedules
Explanation: ***Mite***- *Orientia tsutsugamushi*, the causative agent of **scrub typhus**, is transmitted to humans by the bite of the **larval stage** (chiggers) of mites belonging to the Trombiculidae family, such as *Leptotrombidium deliense*. - Mites are crucial in the infectious cycle because they maintain the pathogen through **transovarial transmission**, acting as both the **vector** and the **reservoir**. *Tick* - Ticks are the vectors for other rickettsial diseases, most notably **Rocky Mountain spotted fever** (*Rickettsia rickettsii*) and tularaemia. - Tick-borne infections typically involve different reservoirs (e.g., small mammals, deer) and produce distinct clinical syndromes from scrub typhus. *Louse* - Lice (specifically the body louse) are the vectors for **epidemic typhus** (*Rickettsia prowazekii*) and trench fever. - Transmission of louse-borne pathogens involves scratching infectious feces into the skin, which is not the mechanism for *Orientia tsutsugamushi*. *Flea* - Fleas, particularly the oriental rat flea, transmit **murine typhus** (*Rickettsia typhi*) and **plague** (*Yersinia pestis*). - This type of vector is typically associated with peridomestic rodents, contrasting with the outdoor, vegetation-associated exposure risk characteristic of **scrub typhus**.
Explanation: ***Primary prevention***- Hand washing is a crucial public health measure that provides **specific protection** by removing SARS-CoV-2 from the skin surface, thereby preventing the entry and establishment of the disease.- This level of prevention focuses on actions taken *before* the onset of disease to reduce the incidence of infection, aligning with efforts like **vaccination** and health education.*Primordial prevention*- This is the earliest stage, aimed at preventing the emergence and establishment of **environmental or social conditions** that may lead to the development of risk factors (e.g., discouraging unhealthy lifestyle trends globally).- It addresses pre-existing **underlying determinants** of health, whereas hand washing directly targets an infectious agent.*Secondary prevention*- This level involves actions aimed at early diagnosis and prompt treatment of an existing condition to halt progression (e.g., large-scale **testing/screening** of asymptomatic cases for COVID-19).- Actions taken at this stage occur *after* the infection has begun but before significant symptoms or complications arise.*Tertiary prevention*- This level focuses on measures taken when the disease has already fully developed, aiming to reduce the severity of **complications**, limit disability, and provide **rehabilitation** (e.g., physical therapy for post-COVID syndrome).- It deals with the management and recuperation phase of established illness, which is not applicable to preventive hygiene practices.
Communicable Disease Control Principles
Practice Questions
Vector-Borne Diseases
Practice Questions
Water-Borne Diseases
Practice Questions
Air-Borne Diseases
Practice Questions
Zoonotic Diseases
Practice Questions
Sexually Transmitted Infections
Practice Questions
HIV/AIDS Control Program
Practice Questions
Tuberculosis Control
Practice Questions
Leprosy Elimination
Practice Questions
Emerging and Re-emerging Infections
Practice Questions
Hospital-Acquired Infections
Practice Questions
Integrated Disease Surveillance Project
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free